Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Mission Bio Blog and Podcast go live! Get the latest news and trends on single-cell multi-omics. Subscribe
X
Scientific presentation

Issues faced when using targeted NGS panels in the clinic for diagnosis, prognosis, and treatment


Alexander Perl, MD
Catherine Smith, MD

Description

Large cancer centers have adopted Next Generation Sequencing (NGS) in the clinic for diagnosis, prognosis, and treatment decisions. Dr. Catherine Smith, from UCSF, discusses the issues faced with targeted panels in the clinic and the differences between amplicon and hybridization methods. While Dr. Alexander Perl, from the University of Pennsylvania, discusses the findings in their collaborative CHRYSALIS study of the FLT3 inhibitor Gilteritinib in relapsed/refractory AML where they used quantifiable single-cell DNA analysis to enable dynamic therapy selection.



VIEW


Scientific presentation
Introducing Europe to single-cell DNA sequencing
Gema Fuerte, MS
Mission Bio (2020)
Scientific presentation
Introducing Asia to single-cell DNA sequencing
Yue Wang, PhD
Mission Bio (2020)
Scientific presentation
How to detect DNA + Protein simultaneously in a single cell
Aik Ooi, PhD
Mission Bio (2020)
Scientific presentation
Agilent Technologies discusses the incorporation of targeted single-cell multi-omics to complement their product portfolio
Kevin Corcoran
Aaron Llanso
Agilent & Mission Bio (2020)